(2015) AASLD guidelines for treatment of chronic hepatitis B. Hepatology , n/a-n/a /Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH. AASLD guidelines for treatment of chronic hepatitis B. Hepatology 2016; 63:261-83....
[4] Fan R, Papatheodoridis G, Sun J, Innes H, Toyoda H, Xie Q, et al. aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis. J Hepatol 2020;73(6):1368-1378. doi: 10...
EASL Clinical Practice Guidelines: Management of Chronic Hepatitis B. In Press 总结(1) ? 替比夫定对慢性乙型肝炎抗病毒治疗疗效是满意的 HBeAg(+)患者24周有45%HBVDNA检测不到 2年有88%HBVDNA检测不到 e 抗原血清转换可达29% 3年e抗原消失可达56% ...
AASLDPRACTICEGUIDELINECorrectionstoAASLDGuidelinesonChronicHepatitisBTotheEditor:WewouldappreciateifcorrectionstoTables2and10inLok..
1．Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560-1599.2．Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma....
美国肝病研究协会(AASLD)慢乙肝指南 优化慢乙肝治疗策略的展望 •用更好的治疗手段以获得停药后疾病持续缓解,–乙肝病毒e抗原(HBeAg)血清转换–乙肝病毒(HBV)DNA检测不到–乙肝病毒表面抗原(HBsAg)血清转换缩短治疗时间，减少不良反应降低核苷类似物耐药风险 •采用标准方法定量检测病毒抗原•更个体化的治疗乙肝•...
美国肝病研究协会（AASLD）慢乙肝指南 海南中医药研究所附属琼岛医院肝病中心 优化慢乙肝治疗策略的展望 •用更好的治疗手段以获得停药后疾病持续缓解,–乙肝病毒e抗原(HBeAg)血清转换–乙肝病毒(HBV)DNA检测不到–乙肝病毒表面抗原(HBsAg)血清转换缩短治疗时间，减少不良反应降低核苷类似物耐药风险 •采用标准方法定量...
原文链接:Jing Zhang, Xiaoqing Liu, Hu Li, et al. Distribution and Liver Histopathology of Gray Zone and Corresponding Immune States in Chronic Hepatitis B Patient According to Different Guidelines. AASLD 2022 Abstract 1219
This update focuses on changes to the guidance since the previous 2020 published update, including ongoing emphasis on recommended universal screening; management recommendations for incomplete treatment adherence; expanded eligibility for simplif i ed chronic HCV infection treatment in adults with minimal ...
Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance NA Terrault, AS Lok, BJ McMahon, KM Chang, JP Hwang, MM Jonas, RS Brown Jr, NH Bzowej, JB Wong FUNDING The funding for the development of this Practice Guidance was provided by th...